About Optimus Drugs Private Limited
Data last updated: 05 January 2026
Optimus Drugs Private Limited is a private limited company based in Shaikpet, Telangana, India, a subsidiary of Sekhmet Pharmaventures Private Limited. It specialises in api manufacturers, a part of the broader pharmaceuticals sector. Incorporated on 02 December 2003, the company has been in operation for over 23 years.
Registered with ROC Hyderabad under CIN U24239TG2003PTC042155.
Capital: an authorised share capital of ₹410 Cr and a paid-up capital of ₹35.14 Cr. Formerly known as Surya Kiran Labs Private Limited. It is led by directors including Srinivasareddy Desireddy and Santosh Kumar Mahil.
Last AGM: 31 January 2025. Financial statements filed for year ended 31 March 2024. Office: Raheja Mindspace It Park, Shaikpet, Telangana.
As per the financials filed for FY 2024, the company reported a revenue of ₹713.55 Cr, a decline of 41% compared to the previous year.
The company has a workforce of approximately 895 employees as per the latest available data. It operates as a subsidiary of Sekhmet Pharmaventures Private Limited. Its group structure includes 2 subsidiaries.
The company is associated with 1 brand - Optimus Pharma. As per MCA filings, the company has open charges of ₹188.61 Cr and satisfied charges of ₹167.44 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website optimuspharma.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address7Th Floor Maximus Towers 2A, Raheja Mindspace It Park Hitec City, Shaikpet, Telangana, India – 500081
-
IndustryPharma, API Manufacturers
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Optimus Drugs Private Limited
Optimus Drugs Private Limited has one previous CIN (Corporate Identification Number): U24239AP2003PTC042155. The current CIN is U24239TG2003PTC042155, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24239TG2003PTC042155 | Current |
| U24239AP2003PTC042155 | Previous |
Associated Brands with Optimus Drugs Private Limited
Optimus Drugs Private Limited operates one associated brand: Optimus Pharma. These brands represent Optimus Drugs Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| APIs, advanced intermediates, and formulations are manufactured. | optimuspharma.com |
Competitors & Alternatives of Optimus Drugs Private Limited
Brands and companies operating in the same space as Optimus Drugs Private Limited include Concord Biotech, BDR Pharmaceuticals Internationals, Almac Group and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Concord Biotech
|
APIs and enzymes are manufactured through fermentation by the CDMO. | Ahmedabad, India, India | 2000 |
BDR Pharmaceuticals Internationals
|
APIs and finished products are developed and manufactured. | Mumbai, India, India | 2003 |
Almac Group
|
Integrated CDMO services for biopharma R&D and manufacturing are offered. | Craigavon, United Kingdom, United Kingdom | 2001 |
Indoco Remedies
|
APIs manufacturing and formulation services are provided in therapeutic segments. | Mumbai, India, India | 1947 |
Pharmaceutics International
|
Pharmaceutical dosage forms are manufactured by this CDMO. | Hunt Valley, United States, United States | 1994 |
Aurobindo Pharma
|
Generic biocatalytic solutions are provided for pharmaceutical applications. | Hyderabad, India, India | 1986 |
Seqens
|
Contract manufacturing services for small molecules and peptides are provided. | Ecully, France, France | 2003 |
Asymchem
|
APIs and peptides are developed and manufactured by Asymchem. | Morrisville, United States, United States | 1995 |
Aptuit
|
Contract research and development services for small molecules are offered. | Greenwich, United States, United States | 2004 |
Continuus Pharma
|
MIT-Novartis spinoff offering continuous manufacturing solutions to remove the proverbial wall between API and FDF manufacturing in small molecule development | Woburn, United States, United States | 2012 |
Business Activity of Optimus Drugs Private Limited
Optimus Drugs Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details for Optimus Drugs Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of Optimus Drugs Private Limited
Optimus Drugs Private Limited is currently managed by 5 directors, with 16 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasareddy Desireddy | Director | 30 Mar 2006 | 20 Years 3 Months | Current |
|
Santosh Kumar Mahil
Also directs:
Optimus Pharma Private Limited, Optimus Life Science Private Limited, Anjan Drug Private Limited and 1 more
|
Additional Director | 26 Jun 2025 | 1 Years 0 Months | Current |
|
Sumit Mohan Nadgir
Also directs:
Optimus Pharma Private Limited, Optimus Life Science Private Limited, Anjan Drug Private Limited and 2 more
|
Additional Director | 01 Apr 2025 | 1 Years 3 Months | Current |
| Durga Prasad Reddy Avula | Director | 22 Sep 2022 | 3 Years 9 Months | Current |
| Uma Rao | Director | 09 May 2024 | 2 Years 2 Months | Current |
Financials of Optimus Drugs Private Limited FY 2024 filings available
Optimus Drugs Private Limited reported revenue of ₹713.55 Cr (down 41.00% YoY) for FY 2024.
Ten-year financial statements for Optimus Drugs Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Optimus Drugs Private Limited
Shareholding and ownership data for Optimus Drugs Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Optimus Drugs Private Limited
Optimus Drugs Private Limited has 2 subsidiary companies. This group structure data is as of FY 2023. The corporate group structure reflects Optimus Drugs Private Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Optimus Life Science Private Limited | U24110TG2020PTC139669 | Locked |
| Optimus Pharma Private Limited | U24239TG2004PTC044232 | Locked |
Showing major subsidiaries. Total: 2.
Charges & Borrowings of Optimus Drugs Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Nov 2022 | Axis Bank Limited | ₹3.61 Cr | Open |
| 10 May 2022 | Hdfc Bank Limited | ₹1 Cr | Open |
| 16 Sep 2017 | Hdfc Bank Limited | ₹55 Cr | Open |
| 15 Sep 2017 | Hdfc Bank Limited | ₹40 Cr | Open |
| 25 Jun 2015 | Others | ₹64 Cr | Open |
Total charge records: 16 View all charges
Employees and EPFO Compliance at Optimus Drugs Private Limited
Optimus Drugs Private Limited has a workforce of 895 employees as of Mar 10, 2025.
Employee and EPFO history for Optimus Drugs Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Optimus Drugs Private Limited
GST registrations and filing compliance for Optimus Drugs Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Optimus Drugs Private Limited
Credit ratings, litigation, and regulatory alerts for Optimus Drugs Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Optimus Drugs Private Limited
MSME payment history for Optimus Drugs Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Optimus Drugs Private Limited
Corporate group structure for Optimus Drugs Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Optimus Drugs Private Limited
MCA filings and documents for Optimus Drugs Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Optimus Drugs Private Limited
Recent News on Optimus Drugs Private Limited
Frequently Asked Questions about Optimus Drugs Private Limited
Optimus Drugs Private Limited is an active private limited company in the pharma sector based in Shaikpet, Telangana, India. It was incorporated on 02 December 2003 (23+ years old) and is registered under CIN U24239TG2003PTC042155. The company has 895 employees.
Optimus Drugs Private Limited reported revenue of ₹713.55 Cr for FY 2024 (down 41.00% YoY).
The current directors of Optimus Drugs Private Limited are:
- Srinivasareddy Desireddy - Director
- Santosh Kumar Mahil - Additional Director
- Sumit Mohan Nadgir - Additional Director
- Durga Prasad Reddy Avula - Director
- Uma Rao - Director
The primary industry of Optimus Drugs Private Limited is pharma. The company specifically operates in api manufacturers. The company is currently active in this sector.
Optimus Drugs Private Limited can be reached at the registered office: 7Th Floor Maximus Towers 2A, Raheja Mindspace It Park Hitec City, Shaikpet, Telangana, India – 500081, or through the website optimuspharma.com.
The authorised capital is ₹410 Cr, and the paid-up capital is ₹35.14 Cr.